| Product Information |
Product name | Edoxaban Intermediate (avoid the patent) |
Synonyms | 4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridine-2-carboxylicacidhydrochloride;5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylicacidhydrochloride;EthanediaMideiMpurityBHCL;5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-carboxylicacidhydrochloride;Thiazolo[5,4-c]pyrChemicalbookidine-2-carboxylicacid,4,5,6,7-tetrahydro-5-Methyl-,hydrochloride(1:1);5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylicacidhydrochloride(forEdoxaban);4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridin;4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridine-2-carboxylicacidHCl;5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride |
CAS No. | 720720-96-7 |
Molecular Formula | C8H11ClN2O2S |
Molecular Weight | 234.7 |
Quality Standard | 99% up by HPLC,S.Impurity < 0.1% |
Appearance | White to off-white powder |
Edoxaban Intermediate CAS 720720-96-7 – Thiazolopyridine Building Block for Edoxaban API Synthesis |
In the pharmaceutical synthesis of anticoagulant APIs, heterocyclic intermediates play an important role in constructing the molecular framework of the final active ingredient. Edoxaban Intermediate CAS 720720-96-7 is chemically known as 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride. It is a key thiazolopyridine building block used in the synthesis of edoxaban, an oral direct factor Xa inhibitor.
As an Edoxaban API Intermediate, this compound contributes the methyl-substituted thiazolopyridine carboxylic acid moiety to the edoxaban molecular structure. Its heterocyclic ring system and carboxylic acid functionality make it an important component in the downstream construction of the API.
Manufacturing Process of Edoxaban Intermediate |
The preparation of Edoxaban Intermediate involves the construction of a fused thiazolopyridine ring system, followed by the introduction of a carboxylic acid group and conversion into its hydrochloride salt. Depending on the selected manufacturing route, the process generally involves several stages:
Heterocyclic Ring Formation: Suitable nitrogen-containing starting materials undergo controlled chemical transformations to construct the thiazolopyridine ring framework.
Carboxyl Group Introduction: Further reaction steps establish the carboxylic acid functionality at the 2-position, which is essential for subsequent coupling reactions.
Hydrochloride Salt Formation: The target compound is converted into its hydrochloride form, followed by suitable isolation and purification.
Purification and Refinement: Crystallization, filtration, and drying may be selected according to the material's properties to remove process-related impurities.
Quality Evaluation: Identity, assay, related substances, and other relevant quality attributes are assessed to maintain batch consistency.
In downstream edoxaban synthesis, the carboxylic acid group can be activated and coupled with the corresponding amino-containing edoxaban fragment to form the characteristic amide linkage. This makes the intermediate particularly important to the assembly of the final API molecule.
Applications in Pharmaceutical Manufacturing |
The primary application of Edoxaban Intermediate CAS 720720-96-7 is in the production of edoxaban API. Its thiazolopyridine structure provides a specific molecular fragment required for the synthesis of the anticoagulant.
For pharmaceutical companies involved in anticoagulant development and production, this intermediate is relevant to synthetic route selection, coupling process development, and commercial API manufacturing. Consistent material quality can help support downstream reaction performance and production reproducibility.
Manufacturing and Sourcing Considerations |
When evaluating an Edoxaban Intermediate Manufacturer, buyers may consider synthetic route maturity, heterocyclic synthesis experience, impurity control, and batch-to-batch consistency. An Edoxaban Intermediate Manufacturer China or CAS 720720-96-7 Manufacturer should have appropriate process controls and the capacity to support the requirements of pharmaceutical intermediate production. These factors are also important when assessing a qualified Pharmaceutical Intermediate Manufacturer.
| Edoxaban Intermediate Supply Support by Rocky Pharm |
If your company needs Edoxaban Intermediate CAS 720720-96-7 for API development or commercial production, Rocky Pharm can assist with sourcing through established pharmaceutical raw material suppliers in China. We help international customers identify suitable supply options based on their product requirements and procurement needs.
Whether you are planning regular purchases or require bulk quantities, contact Rocky Pharm for product details, current market availability, and a competitive quotation. We are ready to support your pharmaceutical raw material sourcing needs.